… Organic and inorganic nanoparticles have been widely exploited for application in biomedicine.
Among inorganic nanoparticles, mesoporous silica nanoparticles (MSNPs) have gained …

… of RES-loaded mesoporous silica nanoparticles (MSNs) for human melanoma treatment. RES
… The encapsulation promoted the amorphization of RES and enhanced the release in vitro …

… Furthermore, to promote the practical application of mesoporous materials in biomedicine,
the long-term … (2010b), using a model of nude mice xenograft with human malignant …

… mesoporous silica nanoparticles (HMSNs) for the encapsulation and targeted release of DTIC
for eradicating melanoma. … Such a CTA + -promoted etching-redeposition formation is the …

… of melanoma tumor growth [33]. Furthermore, Li et al. [38] used a morin derivative that
induced a decrease in cell proliferation and promoted apoptosis in B16-F10 melanoma cells. …

… killing efficiency and a stronger ability to promote the apoptosis of tumor cells than free DTIC…
aPD1 immunotherapy remarkably suppress the melanoma growth and prolong survival time …

… Malignant melanomas, as well as many other human cancers, first metastasize via lymphatic
vessels to the sentinel lymph node through … role in the promotion of cancer metastasis to the …

… concept of targeted therapy of skin malignancies (eg, melanoma) by grafting of specific ligands.
… strategy to overcome this limitation, promoting the incorporation of different hydrophobic …

The poor prognosis associated with malignant melanoma has not changed substantially
over the past 30 years. Targeted molecular therapies, such as immunotherapy, have shown …

… been used to conjugate iron oxide with MSN, either using iron oxide core coated with
mesoporous silica or MSN capped with iron oxide nanoparticles [179,180]. The most employed …